|
 |
J Clin Outcomes Manage
2005 Dec;12(12):629-635
An operative risk management pathway to increase perioperative beta-blocker utilization in patients undergoing elective total hip or knee arthroplasty
Robinson RL, Antonini JM, Hasan S, Bussing R, Vautrain R
Abstract Objective: To assess the impact of an operative risk management pathway that promotes the use of perioperative b blockers. Methods: A before and after intervention cohort study was conducted at a tertiary care referral center. Results: Data from 300 consecutive preintervention and 300 consecutive postintervention total hip and knee arthroplasty patients were gathered. Perioperative b-blocker use increased from 18% to 60% (p < 0.001), with a corresponding reduction in cardiovascular complications (11% versus 1.1%; p < 0.001). The rates of cardiac ischemia (7% versus 1%; p < 0.001), myocardial infarction (3% versus 1%; p = 0.038), angina (4% versus 1%; p = 0.002), congestive heart failure (4% versus 0%; p < 0.001), and hospital length of stay (3.55 days versus 3.9 days; p = 0.005) were reduced in the postintervention group. Conclusion: An operative risk management pathway promoting the use of perioperative b blockers was effective for increasing appropriate utilization of perioperative b blockers and reduced the overall rate of perioperative cardiovascular complications for elective hip or knee arthroplasty.
Original Research
Search the Turner White index to find abstracts of articles published in JCOM.
|
